People with ulcerative colitis may soon have a new medication available to help them, thanks to a global study led by University of Chicago Medicine's David T. Rubin, MD.
Congratulations to Nabsolute Co., Ltd., a biotech startup from the Faculty of Pharmacy, Chulalongkorn University and recipient of the first prize (Cosmetics) at the “In-Cosmetics Global 2024” in Paris, France from April 16 to 18, 2024.
Clinical Trial Finds Oral Medication Significantly Reduced Prurigo Nodularis and Chronic Pruritus of Unknown Origin Symptoms A drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no targeted treatments, according to a new study published in JAMA Dermatology.
The Paul Ehrlich Award for Experimental Research recognizes scientists who have revolutionized the understanding of allergic diseases and immunological mechanisms.
UCLA Health dermatologist Caroline Opene, MD treats patients of all skin tones, but as director of the UCLA Health Skin of Color clinic, she has special expertise in treating skin of color. Below are some of the topics she is often asked about.
In a significant development for medical professionals, a new consensus has been developed to enhance the treatment of second-degree burn wounds. This guideline offers a thorough and systematic method for addressing these frequently occurring injuries, advocating for a standardized approach to care.
Wounds that are superficial for some can be life-threatening for others. With diabetic wounds, healing can be slow, particularly in the feet, increasing the tissue’s susceptibility to infection. Foot ulcers and other diabetic foot complications have similar mortality rates to some cancers, yet progress toward improved treatments has plateaued.
As the warm weather and summer vacations draw more people outdoors, a UT Southwestern Medical Center cancer specialist is reminding everyone to stay vigilant of potential sun damage. Skin cancer is mainly caused by ultraviolet radiation from the sun. And while it is the most common of all cancers in the U.S., it is also one of the most avoidable forms of the disease.
ASCO, the largest event in cancer research, is approaching on May 31st. This year's meeting promises to be particularly groundbreaking, with new findings and innovations that could revolutionize cancer treatment.
Sunburns can be painful and damaging to your skin, while also increasing your risk of skin cancer, the most common cancer in the United States and one of the most preventable. A new survey by the American Academy of Dermatology shows that one in three Americans (36%) got a sunburn in 2023, a significant increase over the previous year.
May is Skin Cancer Awareness month, intended to call attention to the most common, but also most preventable, form of cancer. With summer just around the corner, Dr. Stephanie Lareau with the Virginia Tech Carilion School of Medicine outlined many ways to protect yourself from too much ultraviolet radiation and avoid the dangers of too much sun exposure.
When it comes to skin cancer, most people think of warnings about sunburn and tanning beds. Thoughts of “cancer genes” or inherited risks are reserved for diseases like breast cancer or colon cancer. A new study challenges this status quo by showing that genetics play a larger role in melanoma risk than recognized.
Physicians rarely order genetic screens to assess risk factors for patients with a family history of melanoma because, according to the previous, limited studies, only 2-2.5% of all cases are genetic. For the same reason, insurance companies rarely cover these tests outside of the most extreme situations. In the medical field, genetic testing is generally not offered for cancers that don’t meet a threshold of 5%.
A study from researchers and clinicians led by Cleveland Clinic’s Joshua Arbesman, MD, and Stanford Medicine’s Pauline Funchain, MD (formerly Cleveland Clinic), suggests that melanoma more than meets that threshold.
Skin Brachytherapy, also called radiation seed therapy, offers a non-invasive radiation therapy solution to complement or replace surgery for certain skin cancers. Rajesh V. Iyer, MD, is a radiation oncologist at RWJBarnabas Health and chairman of radiation oncology at Community Medical Center, shares more about this treatment option for patients.
The Icahn School of Medicine at Mount Sinai Health System is spearheading a collaborative effort to investigate dupilumab as a treatment for children with alopecia areata, a disease that causes extensive hair loss.
A new survey from the American Academy of Dermatology revealed that Generation Z adults, ages 18-25, are at risk for skin cancer due to increasing rates of tanning and burning. To encourage safe sun habits, the AAD is shining a spotlight on the ways that people can protect themselves from the most common and one of the most preventable types of cancer — skin cancer — this May for Skin Cancer Awareness Month.